
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Parkinson's Disease (PD) is a progressive, neurodegenerative disorder with the cardinal symptons of bradykinesia, rigidity and tremor, as well as a postural inability in the later stages of the disease. It has been estimated that over 1,000,000 people in the United States are affected by PD with approximately 50,000-60,000 new cases diagnosed each year. The average age of PD onset is 60 years, although persons can onset much later and approximately 4-10% onset prior to the age of 40. The primary neurochemical change in PD is a loss of dopamine in the substantia niger, although it is increasingly recognized that additional neurotransmitters and brain areas are involved. The cause of PD is unknown, and there is currently no cure available.The treatment of PD can be challenging and treatment of early PD can be complex with choice of initial therapy, as well as timing the initiation of therapy. Although there are currently no treatments approved to stop or slow the progression of PD, this is an area of active research, as it is estimated that approximately 60-80% of dopamine neurons are lost by the time of diagnosis. There are several symptomatic treatments available for all stages of PD, including monoamine oxidase type B (MAO-B) inhibitors, dopamine agonists, levodopa, and less commonly, anticholinergics and amantadine. The treatment regimen in the early stage needs to be individualized based on the disease characteristics and life situation of each patient. The goal of therapy in early PD is to identify a treatment strategy to control the parkinsonian symptons, such as motor fluctuations and dyskinesia, without causing adverse events.
This text investigates the clinical complexities and therapeutic strategies required for the effective management of early-stage Parkinson's Disease. Dr. Kelly E. Lyons and Dr. Rajesh Pahwa provide a clinical framework for practitioners, addressing the challenges of initial therapy selection and the timing of treatment initiation. The authors synthesize current medical understanding of neurochemical changes and symptomatic progression to guide individualized patient care plans.
What You Will Find
Medical professionals frequently utilize this text as a concise, high-yield reference for navigating the complexities of early-stage neurodegenerative care. Experts highlight the utility of the pocket-sized format for quick clinical decision-making in fast-paced outpatient settings.
Page Count:
48
Publication Date:
2009-01-22
Publisher:
Oxford University Press
ISBN-10:
0195386493
ISBN-13:
9780195386493
No comments yet. Be the first to share your thoughts!